During 2012, the Chilean Antitrust case denominated “Pharmacies” became one of the leading in terms of investigation conducted by the Fiscalia Nacional Economica and one of the highlighted decisions of the Antitrust Court, Tribunal de Defensa de la Libre Competencia. This paper analyses the basic structure of judgement 119/2012 issued by the Tribunal, and confirmed by Chilean Supreme Court, by decision 2578-2012, which it was written by judge Sergio Muñoz, rejecting an appeal issued by Cruz Verde S.A and Salcobrand S.A. The article also studies the way by which the judges define the relevant market, and discusses some elements about parallel pricing. Furthermore, the case was controversial with respect to to the application of an agreement of conciliation with FASA S.A.
Full Content: SSRN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI